Lipid-lowering response to statins is affected by CYP3A5 polymorphism.
Kivistö KT, Niemi M, Schaeffeler E, Pitkälä K, Tilvis R, Fromm MF, Schwab M, Eichelbaum M, Strandberg T.
Kivistö KT, et al. Among authors: schaeffeler e.
Pharmacogenetics. 2004 Aug;14(8):523-5. doi: 10.1097/01.fpc.0000114762.78957.a5.
Pharmacogenetics. 2004.
PMID: 15284534